Literature DB >> 30181653

Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity.

S Fjalldal1, C Follin1, S Gabery2, P C Sundgren3,4, I M Björkman-Burtscher3,4,5, J Lätt3, P Mannfolk3, C H Nordström6, L Rylander7, B Ekman8, R Cheong2, A Pålsson1, Å Petersén2, E M Erfurth9.   

Abstract

BACKGROUND/
OBJECTIVES: Hypothalamic obesity (HO) occurs in 50% of patients with the pituitary tumor craniopharyngioma (CP). Attempts have been made to predict the risk of HO based on hypothalamic (HT) damage on magnetic resonance imaging (MRI), but none have included volumetry. We performed qualitative and quantitative volumetric analyses of HT damage. The results were explored in relation to feeding related peptides and body fat. SUBJECTS/
METHODS: A cross-sectional study of childhood onset CPs involving 3 Tesla MRI, was performed at median 22 years after first operation; 41 CPs, median age 35 (range: 17-56), of whom 23 had HT damage, were compared to 32 controls. After exclusions, 35 patients and 31 controls remained in the MRI study. Main outcome measures were the relation of metabolic parameters to HT volume and qualitative analyses of HT damage.
RESULTS: Metabolic parameters scored persistently very high in vascular risk particularly among HT damaged patients. Patients had smaller HT volumes compared to controls 769 (35-1168) mm3 vs. 879 (775-1086) mm3; P < 0.001. HT volume correlated negatively with fat mass and leptin among CP patients (rs = -0.67; P < .001; rs = -0.53; P = 0.001), and explained 39% of the variation in fat mass. For every 100 mm3 increase in HT volume fat mass decreased by 2.7 kg (95% CI: 1.5-3.9; P < 0.001). Qualitative assessments revealed HT damage in three out of six patients with normal volumetry, but HT damage according to operation records.
CONCLUSIONS: A decrease in HT volume was associated with an increase in fat mass and leptin. We present a method with a high inter-rater reliability (0.94) that can be applied by nonradiologists for the assessment of HT damage. The method may be valuable in the risk assessment of diseases involving the HT.

Entities:  

Mesh:

Year:  2018        PMID: 30181653     DOI: 10.1038/s41366-018-0185-z

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  8 in total

1.  Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007.

Authors:  Svenja Boekhoff; Brigitte Bison; Maria Eveslage; Panjarat Sowithayasakul; Hermann L Müller
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

2.  Clinical Implication of Individually Tailored Segmentation Method for Distorted Hypothalamus in Craniopharyngioma.

Authors:  A Ram Hong; Miwoo Lee; Jung Hyun Lee; Jung Hee Kim; Yong Hwy Kim; Hyung Jin Choi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-20       Impact factor: 5.555

Review 3.  Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma.

Authors:  Eva-Marie Erfurth
Journal:  Neuroendocrinology       Date:  2020-06-24       Impact factor: 4.914

Review 4.  The Challenging Management of Craniopharyngiomas in Adults: Time for a Reappraisal?

Authors:  Thomas Cuny; Michael Buchfelder; Henry Dufour; Ashley Grossman; Blandine Gatta-Cherifi; Emmanuel Jouanneau; Gerald Raverot; Alexandre Vasiljevic; Frederic Castinetti
Journal:  Cancers (Basel)       Date:  2022-08-07       Impact factor: 6.575

5.  Resting energy expenditure in children at risk of hypothalamic dysfunction.

Authors:  J Van Schaik; M Burghard; M H Lequin; E A van Maren; A M van Dijk; T Takken; L B Rehorst-Kleinlugtenbelt; B Bakker; L Meijer; E W Hoving; M Fiocco; A Y N Schouten-van Meeteren; W J E Tissing; H M van Santen
Journal:  Endocr Connect       Date:  2022-07-21       Impact factor: 3.221

Review 6.  Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities.

Authors:  Jing Li; Hongli Duan; Yan Liu; Lu Wang; Xing Zhou
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

7.  Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood-onset craniopharyngioma.

Authors:  Sigridur Fjalldal; Lars Rylander; Danielle van Westen; Helene Holmer; Cecilia Follin; Sanaz Gabery; Åsa Petersen; Eva Marie Erfurth
Journal:  Clin Endocrinol (Oxf)       Date:  2020-11-17       Impact factor: 3.478

8.  Cognitive interference processing in adults with childhood craniopharyngioma using functional magnetic resonance imaging.

Authors:  Daniel Svärd; Cecilia Follin; Sigridur Fjalldal; Robin Hellerstedt; Peter Mannfolk; Johan Mårtensson; Pia Sundgren; Eva Marie Erfurth
Journal:  Endocrine       Date:  2021-07-22       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.